Medicine

Projects

Projects per year 1975 1989 2002 2003 2005 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2025

• 25 Not started
• 96 Active
• 973 Finished

Projects per year

Search results

• Antibody therapy for pneumococcal disease

  Pirofski, L.

  11/10/16 → 10/31/21

  Project: Research project

  • Serogroup 100%
  • Pneumonia 68%
  • Pneumococcal Infections 59%
  • Monoclonal Antibodies 53%
  • Antibodies 40%

• Cardiac MR to Improve Clinical Risk Prediction in Defibrilator Patients

  Tomaselli, G. F. & Tomaselli, G. F.

  National Heart, Lung, and Blood Institute

  3/1/17 → 2/28/21

  Project: Research project

  • Implantable Defibrillators 100%
  • Primary Prevention 41%
  • Sudden Cardiac Death 36%
  • Magnetic Resonance Imaging 31%
  • Shock 11%

• Cardiac MR to Improve Clinical Risk Prediction in Defibrilator Patients

  Tomaselli, G. F.

  3/1/17 → 2/28/21

  Project: Research project

  • Implantable Defibrillators 100%
  • Primary Prevention 41%
  • Sudden Cardiac Death 36%
  • Magnetic Resonance Imaging 31%
  • Shock 11%

• Achieving smoking cessation milestones in opioid treatment patients: a randomized 2 x 2 factorial trial of directly observed and long-term varenicline

  Nahvi, S. & Nahvi, S.

  National Institute on Drug Abuse

  4/1/17 → 11/30/22

  Project: Research project

  • Varenicline 100%
  • Smoking Cessation 68%
  • Opioid Analgesics 63%
  • Directly Observed Therapy 32%
  • Tobacco 26%

• Achieving smoking cessation milestones in opioid treatment patients: a randomized 2 x 2 factorial trial of directly observed and long-term varenicline

  Nahvi, S.

  4/1/17 → 11/30/21

  Project: Research project

  • Smoking Cessation 100%
  • Varenicline 93%
  • Opioid Analgesics 79%
  • Directly Observed Therapy 55%
  • Withholding Treatment 32%

• AB Sciex 6500+ QTRAP with Selexion for ultra-sensitive metabolomics and lipidomics

  Kurland, I. J.

  4/15/17 → 4/14/19

  Project: Research project

  • Metabolomics 100%
  • Mass spectrometers 55%
  • Isotopes 48%
  • Medical problems 43%
  • Stem cells 37%

• AB Sciex 6500+ QTRAP with Selexion for ultra-sensitive metabolomics and lipidomics

  Kurland, I. J. & Kurland, I. J.

  NIH Office of the Director

  4/15/17 → 4/14/19

  Project: Research project

  • Metabolomics 100%
  • Mass spectrometers 65%
  • Isotopes 56%
  • Medical problems 50%
  • Stem cells 43%

• Core-003

  Keller, M. J. & Shamoon, H.

  National Center for Advancing Translational Sciences

  5/1/17 → 4/30/18

  Project: Research project

• Core-009

  Keller, M. J. & Shamoon, H.

  National Center for Advancing Translational Sciences

  5/1/17 → 4/30/18

  Project: Research project

• Core-004

  Keller, M. J. & Shamoon, H.

  National Center for Advancing Translational Sciences

  5/1/17 → 4/30/18

  Project: Research project

• Core-001

  Keller, M. J. & Shamoon, H.

  National Center for Advancing Translational Sciences

  5/1/17 → 4/30/18

  Project: Research project

• Core-005

  Keller, M. J. & Shamoon, H.

  National Center for Advancing Translational Sciences

  5/1/17 → 4/30/18

  Project: Research project

• Clinical Translational & Implementation Core

  Anastos, K.

  National Institute of Allergy and Infectious Diseases

  5/1/17 → 4/30/22

  Project: Research project

  • Implementation Science 100%
  • HIV 36%
  • Public Health 28%
  • HIV Infections 23%
  • Epidemics 22%

• Patient and Population Health Outcomes Research SWG

  Arnsten, J. H.

  National Institute of Allergy and Infectious Diseases

  5/1/17 → 4/30/22

  Project: Research project

  • Behavioral Sciences 100%
  • Population Health 67%
  • Health Care Outcome Assessment 41%
  • Behavioral Research 39%
  • Social Sciences 34%

• Core-002

  Keller, M. J. & Shamoon, H.

  National Center for Advancing Translational Sciences

  5/1/17 → 4/30/18

  Project: Research project

• Core-006

  Keller, M. J. & Shamoon, H.

  National Center for Advancing Translational Sciences

  5/1/17 → 4/30/18

  Project: Research project

• Core-008

  Keller, M. J. & Shamoon, H.

  National Center for Advancing Translational Sciences

  5/1/17 → 4/30/18

  Project: Research project

• Core-007

  Keller, M. J. & Shamoon, H.

  National Center for Advancing Translational Sciences

  5/1/17 → 4/30/18

  Project: Research project

• Core-010

  Keller, M. J. & Shamoon, H.

  National Center for Advancing Translational Sciences

  5/1/17 → 4/30/18

  Project: Research project

• Development and pilot testing of a PrEP mobile outreach intervention for women

  Blackstock, O. J. & Norton, B. L.

  5/1/17 → 4/30/20

  Project: Research project

  • prophylaxis 100%
  • risk behavior 6%

• Einstein-Rockefeller-CUNY Center for AIDS Research

  Bauman, L. J., Prasad, V. R., Goldstein, H., Berman, J. W., Anastos, K., Kalpana, G. V. & Arnsten, J. H.

  5/1/17 → 4/30/22

  Project: Research project

  • AIDS 100%
  • interdisciplinary research 55%
  • public health 24%
  • access to treatment 23%
  • research implementation 21%

• Beta-catenin in vascular homeostasis and remodeling

  Sibinga, N. E. S. & Sibinga, N. E. S.

  National Heart, Lung, and Blood Institute

  6/15/17 → 2/28/21

  Project: Research project

  • Vascular Remodeling 100%
  • beta Catenin 85%
  • Homeostasis 67%
  • Blood Vessels 58%
  • Smooth Muscle Myocytes 54%

• Beta-catenin in vascular homeostasis and remodeling

  Sibinga, N. E. S.

  6/15/17 → 2/28/21

  Project: Research project

  • Blood Vessels 100%
  • Smooth Muscle Myocytes 93%
  • Homeostasis 77%
  • Atherosclerosis 51%
  • Vascular Remodeling 50%

• Energy Homeostasis: GABAergic and Non-GABAergic POMC neurons

  Jo, Y.

  National Institute of Diabetes and Digestive and Kidney Diseases

  7/1/17 → 6/30/18

  Project: Research project

  • Pro-Opiomelanocortin 100%
  • Neurons 49%
  • Arcuate Nucleus of Hypothalamus 43%
  • Homeostasis 33%
  • Liver 30%

• The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease

  Broder, A. R.

  7/1/17 → 6/30/22

  Project: Research project

  • end stage renal disease 100%
  • mortality 27%
  • drug therapy 7%
  • Schools of medicine 6%
  • action plan 5%

• The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease

  Broder, A. R. & Broder, A. R.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/1/17 → 6/30/22

  Project: Research project

  • end stage renal disease 100%
  • mortality 51%
  • drug therapy 8%
  • Schools of medicine 6%
  • action plan 6%

• Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?

  Cunningham, C. O.

  7/1/17 → 6/30/22

  Project: Research project

  • Medical Marijuana 100%
  • Opioid Analgesics 41%
  • Cannabidiol 28%
  • HIV 25%
  • Dronabinol 25%

• All Africa IeDEA Conference

  Anastos, K. & Nash, D.

  National Institute of Allergy and Infectious Diseases

  7/1/17 → 6/30/18

  Project: Research project

  • Acquired Immunodeficiency Syndrome 100%
  • HIV 92%
  • Epidemiology 88%
  • Databases 67%
  • Africa South of the Sahara 49%

• Early Detection of Hematologic Malignancies in New York City Firefighters Exposed To World Trade Center Dust After The 9/11 Attacks

  Prezant, D. J.

  7/1/17 → 6/30/20

  Project: Research project

  • Firefighters 100%
  • B-Cell Chronic Lymphocytic Leukemia 25%
  • Paraproteinemias 22%
  • Myelodysplastic Syndromes 20%
  • Hematologic Neoplasms 18%

• All Africa IeDEA Conference

  Anastos, K.

  7/1/17 → 6/30/18

  Project: Research project

  • HIV 100%
  • Acquired Immunodeficiency Syndrome 94%
  • Epidemiology 76%
  • Databases 58%
  • Africa South of the Sahara 53%

• Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?

  Arnsten, J. H. & Cunningham, C. O.

  National Institute on Drug Abuse

  7/1/17 → 6/30/22

  Project: Research project

  • Medical Marijuana 100%
  • Opioid Analgesics 57%
  • HIV 43%
  • Pain 33%
  • Cannabidiol 30%

• Role of bacterial aggregation and biofilms in gonococcal pathogenesis

  Stein, D. T.

  7/6/17 → 6/30/21

  Project: Research project

  • lipid-linked oligosaccharides 100%
  • Biofilms 38%
  • Microbial Drug Resistance 26%
  • opacity proteins 24%
  • Neisseria gonorrhoeae 15%

• Advanced Glycation Endproducts and Cardio-Renal Disease

  Kizer, J. & Kizer, J. R.

  National Heart, Lung, and Blood Institute

  7/15/17 → 6/30/22

  Project: Research project

  • Advanced Glycation End Products 100%
  • imidazolone 44%
  • Kidney 35%
  • Mentors 31%
  • Research Personnel 26%

• Chaperone-Mediated Autophagy in Normal Cardiac Biology and Heart Failure

  Kitsis, R. N. & Kitsis, R. N.

  National Heart, Lung, and Blood Institute

  7/15/17 → 6/30/21

  Project: Research project

  • Chaperone-Mediated Autophagy 100%
  • Heart Failure 38%
  • Mitophagy 28%
  • Cardiac Myocytes 9%
  • Macroautophagy 8%

• Advanced Glycation Endproducts and Cardio-Renal Disease

  Kizer, J.

  7/15/17 → 6/30/22

  Project: Research project

  • Advanced Glycation End Products 100%
  • imidazolone 49%
  • Mentors 34%
  • Research Personnel 28%
  • 3-deoxyglucosone 24%

• Chaperone-Mediated Autophagy in Normal Cardiac Biology and Heart Failure

  Kitsis, R. N.

  7/15/17 → 6/30/21

  Project: Research project

  • Chaperone-Mediated Autophagy 100%
  • Mitophagy 24%
  • Heart Failure 8%
  • Cardiac Myocytes 8%
  • Macroautophagy 8%

• Astrocytic Target Mechanisms in Obesity

  Yang, Y. & Yang, Y.

  National Institute of Diabetes and Digestive and Kidney Diseases

  8/1/17 → 7/31/21

  Project: Research project

  • Obesity 100%
  • Astrocytes 94%
  • Adenosine 63%
  • Agouti-Related Protein 61%
  • Diet 35%

• Astrocytic Target Mechanisms in Obesity

  Yang, Y.

  8/1/17 → 7/31/21

  Project: Research project

  • Obesity 100%
  • Astrocytes 87%
  • Adenosine 58%
  • Agouti-Related Protein 57%
  • Diet 32%

• Buprenorphine treatment at syringe exchanges to reduce opioid misuse and HIV risk

  Fox, A. D.

  8/1/17 → 2/28/22

  Project: Research project

  • Buprenorphine 100%
  • Opioid Analgesics 48%
  • Needle-Exchange Programs 47%
  • Therapeutics 16%
  • HIV 16%

• Minimizing losses from HIV care under universal treatment in Rwanda

  Ross, J. & Ross, J.

  NATIONAL INSTITUTE OF MENTAL HEALTH

  8/4/17 → 7/31/18

  Project: Research project

  • Rwanda 100%
  • HIV 50%
  • Therapeutics 12%
  • Africa South of the Sahara 10%
  • Health Services 8%

• Minimizing losses from HIV care under universal treatment in Rwanda

  Ross, J.

  8/4/17 → 7/31/21

  Project: Research project

  • HIV 100%
  • Rwanda 59%
  • Therapeutics 57%
  • Africa South of the Sahara 45%
  • Health Services 36%

• Leveraging the electronic health record to reduce opioid analgesic prescriptions

  Bachhuber, M. A.

  National Institute on Drug Abuse

  8/15/17 → 9/30/18

  Project: Research project

  • Opioid Analgesics 100%
  • Electronic Health Records 86%
  • Prescriptions 77%
  • Implementation Science 11%
  • Research Personnel 10%

• Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living with Hepatitis C-The HCV-ACCELERATE Trial

  Akiyama, M. J. & Akiyama, M. J.

  National Institute on Drug Abuse

  8/15/17 → 3/31/20

  Project: Research project

  • Hepacivirus 100%
  • Hepatitis C 84%
  • Criminal Law 37%
  • Mentors 22%
  • Risk-Taking 17%

• Leveraging the electronic health record to reduce opioid analgesic prescriptions

  Bachhuber, M. A.

  8/15/17 → 7/31/22

  Project: Research project

  • Opioid Analgesics 100%
  • Prescriptions 41%
  • Electronic Health Records 28%
  • Implementation Science 10%
  • Research Personnel 9%

• Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living with Hepatitis C-The HCV-ACCELERATE Trial

  Akiyama, M. J.

  8/15/17 → 3/31/22

  Project: Research project

  • Hepacivirus 100%
  • Criminal Law 35%
  • Mentors 20%
  • Risk-Taking 16%
  • HIV 11%

• Antibodies associated with protection against tuberculosis in nonhuman primates

  Achkar, J. M. & Achkar, J. M.

  National Institute of Allergy and Infectious Diseases

  8/18/17 → 7/31/20

  Project: Research project

  • Tuberculosis 100%
  • Primates 89%
  • Antibodies 54%
  • Infections 32%
  • Antigens 19%

• Antibodies associated with protection against tuberculosis in nonhuman primates

  Achkar, J. M.

  8/18/17 → 7/31/20

  Project: Research project

  • Tuberculosis 100%
  • Infections 30%
  • Primates 19%
  • Antigens 18%
  • Macaca 15%

• Gene therapy of alcoholic liver disease

  Wang, D. Q. H. & Wang, D. Q. H.

  National Institute on Alcohol Abuse and Alcoholism

  8/20/17 → 7/31/20

  Project: Research project

  • Alcoholic Liver Diseases 100%
  • Adeno-associated virus-2 75%
  • Ethanol 67%
  • Genetic Therapy 62%
  • Liver 41%

• Gene therapy of alcoholic liver disease

  Wang, D. Q. H.

  8/20/17 → 7/31/20

  Project: Research project

  • Alcoholic Liver Diseases 100%
  • Adeno-associated virus-2 75%
  • Ethanol 67%
  • Liver 41%
  • Triglycerides 39%

• Developing and pilot testing an intervention to increase opioid tapering in primary care

  Perez, H. R. & Perez, H. R.

  National Institute on Drug Abuse

  9/1/17 → 8/31/18

  Project: Research project

  • Opioid Analgesics 100%
  • Primary Health Care 87%
  • Pain 65%
  • Chronic Pain 29%
  • Retention in Care 23%